Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression

Kartik Goel1, Shruti Rathore1,2, Prisha Warikoo1

  • 1Eicher-Shroff Centre for Stem Cell Research, Dr. Shroff's Charity Eye Hospital, Kedarnath Lane, Daryaganj, 5027, 110002, New Delhi, India.

Scientific Reports
|December 25, 2025
PubMed

Insights

Ocular Surface Squamous Neoplasia (OSSN) involves significant gene expression changes in inflammation and cell cycle control. This study reveals a pro-inflammatory and proliferative profile in OSSN, offering targets for new therapies.

Area of Science:

  • Ophthalmology
  • Oncology
  • Molecular Biology

Background:

  • Ocular Surface Squamous Neoplasia (OSSN) is a group of eye cancers impacting vision.
  • Understanding the molecular basis of OSSN progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the transcriptomic landscape of OSSN.
  • To identify molecular mechanisms driving OSSN development and progression.

Main Methods:

  • RNA-sequencing was performed on conjunctival tissues from OSSN patients and healthy controls.
  • Gene expression alterations and pathway enrichment analyses were conducted.

Main Results:

  • Significant dysregulation of genes involved in inflammation (e.g., IL6, TNFα, IL1β), immune response (e.g., CXCL9, CXCL11, IFNα), cell cycle (e.g., TP53), and stress responses were observed.
  • Activated pathways included Interferon-α, Interferon-γ, IL6/JAK-STAT3 signaling, inflammatory response, p53 signaling, and G2M checkpoint.
  • OSSN samples exhibited a pro-inflammatory and proliferative transcriptomic profile.

Conclusions:

  • OSSN is characterized by chronic immune signaling and disrupted cell cycle control.
  • These findings provide insights into OSSN's molecular drivers.
  • Identified pathways may serve as therapeutic targets for OSSN management.